Suchergebnisse - "Nitschmann, S"

PubPharm (10)

1

Obesity treatment with semaglutide

enthalten in: Der Internist | 2021

von Blüher, M. | Nitschmann, S.

2

Treatment options for patients with suboptimally controlled type 1 diabetes

enthalten in: Der Internist | 2019

von Martin, S. | Nitschmann, S.

3

Cardiovascular effects of liraglutide therapy in patients with type 2 diabetes : Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results (LEADER)

enthalten in: Der Internist | 2017

von Meier, J. | Nitschmann, S.

CommentOn: N Engl J Med. 2016 Jul 28;375(4):311-22. - PMID 27295427

4

New therapy option for type 2 diabetes mellitus : EMPA-REG study

enthalten in: Der Internist | 2016

von Windler, E. | Nitschmann, S.

CommentOn: N Engl J Med. 2015 Nov 26;373(22):2117-28. - PMID 26378978

5

New antihyperglycemic drugs. Examination of cardiovascular outcomes with alogliptin versus standard of care (EXAMINE) and saxagliptin assessment of vascular outcomes recorded in patients with diabetes mellitus-thrombolysis in myocardial infarction (SAVOR-TIMI 53)

enthalten in: Der Internist | 2014

von Gallwitz, B. | Nitschmann, S.

CommentOn: N Engl J Med. 2013 Oct 3;369(14):1317-26. - PMID 23992601

6

Intensive or conventional glucose control in critically ill patients : NICE-SUGAR (The Normoglycemia in Intensive Care Evaluation-Survival Using Glucose Algorithm Regulation Study)

enthalten in: Der Internist | 2010

von Jacob, S. | Nitschmann, S.

CommentOn: N Engl J Med. 2009 Mar 26;360(13):1283-97. - PMID 19318384

7

Revascularization in patients with type 2 diabetes and coronary artery disease : BARI 2D (Bypass Angioplasty Revascularization Investigation 2 Diabetes) Study Group

enthalten in: Der Internist | 2010

von Störk, S. | Ertl, G. | Nitschmann, S.

CommentOn: N Engl J Med. 2009 Jun 11;360(24):2503-15. - PMID 19502645

8

Optimal therapeutic strategy in type 2 diabetes mellitus

enthalten in: Der Internist | 2009

von Scherbaum, W. | Nitschmann, S.

9

Influence of diabetes incidence by ramipril and rosiglitazone : DREAM study (diabetes reduction assessment with ramipril and rosiglitazone medication)

enthalten in: Der Internist | 2007

von Standl, E. | Nitschmann, S.

10

Macrovascular secondary prevention with pioglitazone in diabetics. PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events)

enthalten in: Der Internist | 2007

von Nitschmann, S.

1
[1]